Clinical Trial Update: Efficacy and Safety of Pulsatile Gonadotropin Releasing Hormone Pump Treatment in Patients With Idiopathic Hypogonadotropic Hypogonadism [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the efficacy and safety of pulsatile GnRH pump therapy in patients with idiopathic hypogonadotropic hypogonadism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Hypogonadotropic Hypogonadism

Drugs mentioned

• Pulsatile Gonadotropin-Releasing Hormone Pump (Gonadotropin-releasing hormone (GnRH) pump therapy)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Idiopathic Hypogonadotropic Hypogonadism | Phase 4 | Status: UNKNOWN